Device Endo-Mechanical

Monarch Platform

Payments companies reported to CMS as associated with Monarch Platform. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$1.8Massociated payments (2023-2025)

1,479clinicians with associated payments

5companies reporting

By year

2023 $565K

2024 $652K

2025 $588K

Payments reported as associated with Monarch Platform, per program year, as reported to CMS.

Who makes it

Specialties most often involved

Pulmonary Disease $1.2M

Thoracic Surgery (Cardiothoracic Vascular Surgery) $217K

Urology $133K

Critical Care Medicine (Internal Medicine) $84K

Orthopaedic Surgery $61K

Internal Medicine $34K

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with Monarch Platform

These are the largest totals companies reported as associated with Monarch Platform. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

Clinician	Location	Specialty	Associated payments (2023-2025)
Gustavo Cumbo Nacheli	Grand Rapids, MI	Pulmonary Disease	$259,568.16
Raed Alnajjar	Detroit, MI	Thoracic Surgery (Cardiothoracic Vascular Surgery)	$130,370.24
Samir Makani	San Diego, CA	Pulmonary Disease	$114,717.82
Christopher Manley	Philadelphia, PA	Pulmonary Disease	$102,163.96
Faisal Khan	Greenwood, IN	Pulmonary Disease	$100,685.38
Michael Mullins	Savannah, GA	Pulmonary Disease	$77,337.84
Cory Edgar	Farmington, CT	Orthopaedic Surgery	$61,037.06
Brian Shaller	Stanford, CA	Pulmonary Disease	$58,785.63
Jaime Landman	Orange, CA	Urology	$45,522.34
Grant Pierson	Joplin, MO	Pulmonary Disease	$45,463.08

Prescribed Monarch Platform?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

What this means, and what it doesn't

These payments are legal and common. Drug and device makers routinely pay for meals at educational events, consulting, speaking, travel, and research. Companies are required by federal law to report them; that's why this data exists.
A payment is not evidence of wrongdoing. Most clinicians who accept industry payments provide excellent care. Research payments in particular often reflect participation in clinical trials.
Context beats raw numbers. A few hundred dollars in sandwiches over several years is typical. What's worth understanding is scale, source, and purpose, which is what this page shows.
The data comes from companies, not doctors. Figures are "as reported to CMS" by the paying companies. Clinicians can dispute records through CMS's official process.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.